The COVID-19 pandemic poses a threat to our antibiotic infrastructure, which is already compromised due to a lack of new therapies. That threat makes antimicrobial stewardship even more important.
Patients at the greatest risk for secondary infections, particularly infections that are resistant to first-line antibiotics, include people who are already vulnerable due to other conditions and diseases—like COVID-19. Because of that, antimicrobial resistance poses a significant additional threat, especially as healthcare systems become overburdened.
According to the Centers for Disease Control and Prevention’s (CDC) Flu View, seasonal influenza activity in the U.S. is currently high. Thousands have already been hospitalized this season from influenza-associated illnesses and flu activity has continued to increase.